TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

93 hedge funds and large institutions have $101M invested in Tvardi Therapeutics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

13% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 15

70% less capital invested

Capital invested by funds: $341M → $101M (-$240M)

Holders
93
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$91K
Puts
$98K
Net Calls
Net Calls Change

Top Buyers

1
+$2.66M
2
+$2.49M
3
+$2.36M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.02M
5
ARTA
A.R.T. Advisors
New York
+$770K

Top Sellers

1
-$15.2M
2
-$14.2M
3
-$8.94M
4
PCA
Private Capital Advisors
Connecticut
-$4.16M
5
SFM
Sphera Funds Management
Israel
-$3.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$574K
27
$559K
28
$556K
29
$533K
30
$497K
31
$438K
32
$366K
33
$348K
34
$346K
35
$315K
36
$314K
37
$306K
38
$304K
39
$304K
40
$266K
41
$258K
42
$191K
43
$190K
44
$188K
45
$182K
46
$172K
47
$172K
48
$152K
49
$140K
50
$134K
1
2
3 4 5